Delivery Order SPE2DB20D2002-SPE2DB25FL41U
- Not listed
- The Defense Logistics Agency awarded a $1,476.93 delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Modafinil 100 mg tablets (30-count) with completion scheduled for September 8, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $3,583.68 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This firm fixed price contract, with an ultimate completion date of August 25, 2025, represents a non-set-aside competitive award supporting the federal government's pharmaceutical procurement needs. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,644.33 to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (30-count units), with an ultimate completion date of June 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively on June 3, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,370.31 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,843.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Modafinil 100 mg tablets in 30-count quantities. This non-set-aside delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, is scheduled for completion by July 22, 2025, with performance conducted at the contractor's Conshohocken, Pennsylvania facility....
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $8,125.97. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $2,276.86 to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (30-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $3,785.58 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on June 6, 2025, with completion targeted for June 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $6,825.48 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on September 11, 2025, with a completion date of September 12, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply relationship with the federal government. The award is being fulfilled from the vendor's...
- The Defense Logistics Agency awarded a $3,363.00 delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) under a firm fixed price contract, with an ultimate completion date of August 14, 2025. This non-set-aside award was competitively procured and represents a single delivery order fulfillment for pharmaceutical supplies supporting federal medical needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL41UDelivery Order
The Defense Logistics Agency awarded a $3,604.85 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30. This competitively awarded, firm fixed-price contract carries an ultimate completion date of May 9, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA Troop Support Medical (SPE2DX), a $999.99 billion indefinite delivery vehicle extending through December 2026 that enables the company to furnish a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award carries no set-aside designation, confirming AmerisourceBergen's competitive capability to meet federal pharmaceutical procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 5/8/25 |